The FDA now accepts RWE for device submissions without needing identifiable patient data, facilitating the use of large, de-identified databases. This change addresses previous limitations that ...

Because clinical trials do not mimic the real-world application of multiple myeloma treatments, Ajai Chari, MD, discussed the variety of patient factors clinicians should consider in their practice.

In an era of AI “hype,” I sometimes find that something critical is lost in the conversation. Specifically, there’s a yawning gap between AI research and real-world application. Though many ...